ERBB2 and breast carcinoma: Additionally, we conducted an exploratory analysis to discuss the relationship between INPS and the HER-2 low expression subtype, as it has become clear from an increasing number of studies that patients with HER-2 low expression breast cancer may have a different prognosis than those with HER-2 negative and positive breast cancer.